ArticleFrontiers in nutrition2026
From evidence to implementation: a stakeholder power-interest and social network analysis of potassium-enriched low-sodium salt governance in China.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To characterize the stakeholder landscape and documented governance relationships surrounding the promotion and implementation of potassium-enriched low-sodium salt in China, and to examine institutional and relational patterns relevant to evidence translation. Methods: We conducted a structured desk review of 115 publicly accessible policy and regulatory documents, industry and implementation materials, and academic and grey-literature sources identified through searches completed in April 2025. Stakeholders were classified by sector and jurisdiction. Two coders independently assessed stakeholder power and interest using predefined documentary criteria and mapped stakeholders into four power-interest categories. Social network analysis was used to examine documented policy/regulatory, technical advisory, collaboration, and advocacy/promotion relationships. Results: Eighty-three stakeholders were identified across eight categories. Government agencies constituted the largest group (36, 43.4%), followed by professional associations (20, 24.1%) and academic institutions (14, 16.9%). Eight stakeholders (9.6%) were classified as Key Players, 21 (25.3%) as Supporters, 27 (32.5%) as Potential Allies, and 27 (32.5%) as Monitored Stakeholders. Key Players were concentrated among a small number of government, public-health, industry, professional, and media actors, whereas many high-power government bodies had limited documented potassium-enriched low-sodium salt-specific engagement. The four relationship-specific networks contained 25-57 participating stakeholders and had low densities of 0.03-0.10. Policy/regulatory relationships were centered on national and provincial health authorities, while advocacy and technical advisory ties were concentrated around the collective categories of the public and healthcare providers, respectively. Conclusion: The documented stakeholder landscape was characterized by uneven alignment of power, interest, and institutional connectivity. These patterns present governance challenges for evidence translation but do not establish the causes of limited scale-up. Stronger engagement among high-power actors and clearer coordination across regulatory, technical, industry, and implementation networks are needed to support wider implementation of potassium-enriched low-sodium salt.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.